Patients Eagerly Awaited a Generic Drug. Then They Saw the Price.
Teva Pharmaceuticals announced it would sell a “lower-cost” alternative to Syprine, an old drug that costs more than $21,000. But the new generic version costs nearly as much.
from NYT > Health http://ift.tt/2opx8DA
via health&fitness
Aucun commentaire:
Enregistrer un commentaire